FDA approves Romvimza for tenosynovial giant cell tumor (TGCT)
The U.S. Food and Drug Administration (FDA) has approved vimseltinib (Romvimza) for adult patients with a rare condition ...
News Medical on MSN5h
Vimseltinib gains FDA approval for treating tenosynovial giant cell tumor
The U.S. Food and Drug Administration (FDA) has approved vimseltinib (RomvimzaTM) for adult patients with a rare condition called tenosynovial giant cell tumor (TGCT). TGCT is a tumor of the tissue ...
BlackDoctor1h
7 Little-Known Side Effects of CML Treatment – & How to Handle Them
From crippling fatigue to brain fog, CML treatment can affect your body in ways that go beyond the usual side effects.